Evidence map›Paper›PMID 35385604›Full record

ArticleCancer cytopathology2022

Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.

Austin B Wiles, Matthew Gabrielson, Zubair W Baloch, William C Faquin, Vickie Y Jo, Fabiano Callegari, Ivana Kholova, Sharon Song, Barbara A Centeno, Syed Z Ali and 7 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Cancer cytopathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Secretory carcinoma in the parotid gland: A case report.Molecular and clinical oncology · 2026
    Article
  3. Clinicopathological characteristics, incidence trends, and prognostic factors of salivary gland secretory carcinoma: a SEER database analysis (2011-2021).European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Parotid Gland Tumors: Molecular Diagnostic Approaches.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 4 countries.

Austin B WilesDepartment of Pathology, Virginia Commonwealth University, Richmond, Virginia.ORCID 0000-0003-2090-4333
Matthew GabrielsonDepartment of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
Zubair W BalochDepartment of Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
William C FaquinDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-9043-7171
Vickie Y JoDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-4808-2714
Fabiano CallegariDepartment of Pathology, Federal University of Sao Paulo, Sao Paulo, Brazil.
Ivana KholovaDepartment of Pathology, Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.ORCID 0000-0003-4089-0450
Sharon SongDepartment of Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Barbara A CentenoDepartment of Pathology, Moffitt Cancer Center, Tampa, Florida.
Syed Z AliDepartment of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
Satu TommolaDepartment of Pathology, Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
Guido FaddaDepartment of Pathology, Catholic University of Rome, Rome, Italy.
Gianluigi PetroneDepartment of Pathology, Catholic University of Rome, Rome, Italy.
He WangDepartment of Pathology, Yale University, New Haven, Connecticut.
Esther D RossiDepartment of Pathology, Catholic University of Rome, Rome, Italy.ORCID 0000-0003-3819-4229
Liron PantanowitzDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-8182-5503
Zahra MalekiDepartment of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.ORCID 0000-0003-3273-4802
Johns Hopkins Hospital · USUniversità Cattolica del Sacro Cuore · ITHospital of the University of Pennsylvania · USTampere University of Applied Sciences · FIBrigham and Women's Hospital · USMassachusetts General Hospital · USMoffitt Cancer Center · USUniversidade Federal de São Paulo · BRUniversity of Michigan · USVirginia Commonwealth University · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSecretory carcinoma (SC) of the salivary gland is a rare entity with limited published literature on cytomorphology. The authors present the largest cohort to date of SC fine-needle aspiration (FNA) cases.

methodsFNA cases of histologically confirmed SC were retrospectively retrieved from 12 academic institutions in the United States, Italy, Finland, and Brazil. The collated data included patient demographics, imaging findings, cytopathologic diagnoses according to the Milan System for Reporting Salivary Gland Cytopathology, cytomorphologic characteristics, and immunohistochemical/molecular profiles.

resultsIn total, 40 SCs were identified (male-to-female ratio, 14:26) in patients with a mean age of 52 years (age range, 13-80 years). Ultrasound imagining revealed a hypoechoic, ovoid, poorly defined, or lobulated mass. The most common primary site was the parotid gland (30 of 40 tumors). Regional lymph node metastasis (9 patients) and distant metastasis (4 patients; brain, liver, lungs, and mediastinum) were noted. Two patients died of disease. FNA smears were cellular and demonstrated mainly large, round cells with intracytoplasmic vacuoles or granules and round-to-oval nuclei with smooth nuclear contour, minimal irregularities, and prominent nucleoli arranged predominantly in clusters, papillary formations, and single cells. The background was variable and contained inflammatory cells, mucin, or proteinaceous material. The diagnoses were malignant (19 of 38 tumors; 50%), suspicious for malignancy (10 of 38 tumors; 26%), salivary gland neoplasm of uncertain malignant potential (7 of 38 tumors; 18%), and atypia of undetermined significance (2 of 38 tumors; 6%) according to the Milan System for Reporting Salivary Gland Cytopathology. Two malignant cases (2 of 40 tumors; 5%) were metastases. The neoplastic cells were immunoreactive for S100 (23 of 24 tumors), mammaglobin (18 of 18 tumors), GATA-3 (13 of 13 tumors), AE1/AE3 (7 of 7 tumors), and vimentin (6 of 6 tumors). ETV6-NTRK3 fusion was detected in 32 of 33 tumors by fluorescence in situ hybridization (n = 32) and next-generation sequencing (n = 1).

conclusionsFamiliarity with cytomorphologic features and the immunohistochemical/molecular profile of SC can enhance diagnostic accuracy.

Indexed as

CarcinomaSalivary Gland NeoplasmsAdolescentAdultAgedAged, 80 and overBreast NeoplasmsFemaleHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedMucinsRetrospective StudiesSalivary GlandsVimentinMucinsVimentincytologyETV6-NTRK3fine-needle aspirationmammaglobinmammary analogue secretory carcinomaMilan System for Reporting Salivary Gland Cytopathologysalivary glandsecretory carcinoma

Identifiers

PMID35385604
PMCPMC9545582
OpenAlexW4223624132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.